Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis

Yai-Ping Hsiao,1 Hui-Ting Chen,1 Yu-Chih Liang,2 Tse-En Wang,1 Kai-Hung Huang,3 Cheng-Chih Hsu,3 Hong-Jen Liang,4 Chung-Hsiung Huang,5 Tong-Rong Jan1 1Department of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan; 2School of Medical Laboratory Sci...

Full description

Bibliographic Details
Main Authors: Hsiao YP, Chen HT, Liang YC, Wang TE, Huang KH, Hsu CC, Liang HJ, Huang CH, Jan TR
Format: Article
Language:English
Published: Dove Medical Press 2020-01-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/development-of-nanosome-encapsulated-honokiol-for-intravenous-therapy--peer-reviewed-article-IJN
_version_ 1831591740683845632
author Hsiao YP
Chen HT
Liang YC
Wang TE
Huang KH
Hsu CC
Liang HJ
Huang CH
Jan TR
author_facet Hsiao YP
Chen HT
Liang YC
Wang TE
Huang KH
Hsu CC
Liang HJ
Huang CH
Jan TR
author_sort Hsiao YP
collection DOAJ
description Yai-Ping Hsiao,1 Hui-Ting Chen,1 Yu-Chih Liang,2 Tse-En Wang,1 Kai-Hung Huang,3 Cheng-Chih Hsu,3 Hong-Jen Liang,4 Chung-Hsiung Huang,5 Tong-Rong Jan1 1Department of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan; 2School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 10617, Taiwan; 3Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan; 4Department of Food Science, Yuanpei University, Hsinchu 30015, Taiwan; 5Department of Food Science, National Taiwan Ocean University, Keelung 20224, TaiwanCorrespondence: Tong-Rong JanDepartment and Graduate Institute of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, No.1, Sec. 4, Roosevelt Road, Taipei 10617, Taiwan, ROCTel +886-2-33661287Fax +886-2-23661475Email tonyjan@ntu.edu.twChung-Hsiung HuangDepartment of Food Science, National Taiwan Ocean University, No.2, Beining Road, Keelung 20224, TaiwanTel +886-2-24622192#5115Email huangch@mail.ntou.edu.twBackground: Honokiol has been reported to possess anti-inflammatory and neuroprotective activities. However, the poor aqueous solubility of honokiol limits its clinical application for systemic administration.Purpose: This study aims to develop a novel formulation of nanosome-encapsulated honokiol (NHNK) for intravenous therapy against mouse experimental autoimmune encephalomyelitis (EAE) that mimics human multiple sclerosis.Methods: Nanosomes and NHNK were prepared by using an ultra-high pressure homogenization (UHPH) method. Mice were treated with NHNK or empty nanosomes during the peak phase of EAE symptoms. Symptoms of EAE were monitored and samples of the spinal cord were obtained for histopathological examinations.Results: The stock of NHNK containing honokiol in the nanosome formulation, which showed the structure of single phospholipid bilayer membranes, was well formulated with the particle size of 48.0 ± 0.1 nm and the encapsulation efficiency 58.1 ± 4.2%. Intravenous administration of NHNK ameliorated the severity of EAE accompanied by a significant reduction of demyelination and inflammation in the spinal cord. Furthermore, NHNK decreased the number of IL-6+, Iba-1+TNF +, Iba-1+IL-12 p40+, and CD3+IFN-γ+ cells infiltrating the spinal cord.Conclusion: The UHPH method simplified the preparation of NHNK with uniformly distributed nanosize and high encapsulation efficiency. Intravenous administration of NHNK ameliorated the severity of EAE by suppressing the infiltration of activated microglia and Th1 cells into the spinal cord. Collectively, these results suggest that the formulation of NHNK is a prospective therapeutic approach for inflammatory CNS diseases, such as multiple sclerosis.Keywords: experimental autoimmune encephalomyelitis, honokiol, nanosome, neuroinflammation, ultra-high pressure homogenization
first_indexed 2024-12-18T01:30:26Z
format Article
id doaj.art-30eb5c5173cc4b7684bf86974bc0b784
institution Directory Open Access Journal
issn 1178-2013
language English
last_indexed 2024-12-18T01:30:26Z
publishDate 2020-01-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-30eb5c5173cc4b7684bf86974bc0b7842022-12-21T21:25:37ZengDove Medical PressInternational Journal of Nanomedicine1178-20132020-01-01Volume 15172950880Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune EncephalomyelitisHsiao YPChen HTLiang YCWang TEHuang KHHsu CCLiang HJHuang CHJan TRYai-Ping Hsiao,1 Hui-Ting Chen,1 Yu-Chih Liang,2 Tse-En Wang,1 Kai-Hung Huang,3 Cheng-Chih Hsu,3 Hong-Jen Liang,4 Chung-Hsiung Huang,5 Tong-Rong Jan1 1Department of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan; 2School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 10617, Taiwan; 3Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan; 4Department of Food Science, Yuanpei University, Hsinchu 30015, Taiwan; 5Department of Food Science, National Taiwan Ocean University, Keelung 20224, TaiwanCorrespondence: Tong-Rong JanDepartment and Graduate Institute of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, No.1, Sec. 4, Roosevelt Road, Taipei 10617, Taiwan, ROCTel +886-2-33661287Fax +886-2-23661475Email tonyjan@ntu.edu.twChung-Hsiung HuangDepartment of Food Science, National Taiwan Ocean University, No.2, Beining Road, Keelung 20224, TaiwanTel +886-2-24622192#5115Email huangch@mail.ntou.edu.twBackground: Honokiol has been reported to possess anti-inflammatory and neuroprotective activities. However, the poor aqueous solubility of honokiol limits its clinical application for systemic administration.Purpose: This study aims to develop a novel formulation of nanosome-encapsulated honokiol (NHNK) for intravenous therapy against mouse experimental autoimmune encephalomyelitis (EAE) that mimics human multiple sclerosis.Methods: Nanosomes and NHNK were prepared by using an ultra-high pressure homogenization (UHPH) method. Mice were treated with NHNK or empty nanosomes during the peak phase of EAE symptoms. Symptoms of EAE were monitored and samples of the spinal cord were obtained for histopathological examinations.Results: The stock of NHNK containing honokiol in the nanosome formulation, which showed the structure of single phospholipid bilayer membranes, was well formulated with the particle size of 48.0 ± 0.1 nm and the encapsulation efficiency 58.1 ± 4.2%. Intravenous administration of NHNK ameliorated the severity of EAE accompanied by a significant reduction of demyelination and inflammation in the spinal cord. Furthermore, NHNK decreased the number of IL-6+, Iba-1+TNF +, Iba-1+IL-12 p40+, and CD3+IFN-γ+ cells infiltrating the spinal cord.Conclusion: The UHPH method simplified the preparation of NHNK with uniformly distributed nanosize and high encapsulation efficiency. Intravenous administration of NHNK ameliorated the severity of EAE by suppressing the infiltration of activated microglia and Th1 cells into the spinal cord. Collectively, these results suggest that the formulation of NHNK is a prospective therapeutic approach for inflammatory CNS diseases, such as multiple sclerosis.Keywords: experimental autoimmune encephalomyelitis, honokiol, nanosome, neuroinflammation, ultra-high pressure homogenizationhttps://www.dovepress.com/development-of-nanosome-encapsulated-honokiol-for-intravenous-therapy--peer-reviewed-article-IJNexperimental autoimmune encephalomyelitishonokiolnanosomeneuroinflammationultra-high pressure homogenization
spellingShingle Hsiao YP
Chen HT
Liang YC
Wang TE
Huang KH
Hsu CC
Liang HJ
Huang CH
Jan TR
Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
International Journal of Nanomedicine
experimental autoimmune encephalomyelitis
honokiol
nanosome
neuroinflammation
ultra-high pressure homogenization
title Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
title_full Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
title_fullStr Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
title_full_unstemmed Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
title_short Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
title_sort development of nanosome encapsulated honokiol for intravenous therapy against experimental autoimmune encephalomyelitis
topic experimental autoimmune encephalomyelitis
honokiol
nanosome
neuroinflammation
ultra-high pressure homogenization
url https://www.dovepress.com/development-of-nanosome-encapsulated-honokiol-for-intravenous-therapy--peer-reviewed-article-IJN
work_keys_str_mv AT hsiaoyp developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis
AT chenht developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis
AT liangyc developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis
AT wangte developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis
AT huangkh developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis
AT hsucc developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis
AT lianghj developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis
AT huangch developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis
AT jantr developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis